Literature DB >> 21029206

Acne fulminans: explosive systemic form of acne.

R Zaba1, Ra Schwartz, S Jarmuda, M Czarnecka-Operacz, W Silny.   

Abstract

Acne fulminans (AF) is a rare severe form of acne vulgaris associated with systemic symptoms. It primarily affects male adolescents. Although the aetiology of AF remains unknown, many theories have been advanced to explain it. There have been reported associations with increased androgens, autoimmune complex disease and genetic pre-disposition. The disease is destructive, with the acute onset of painful, ulcerative nodules on the face, chest and back. The associated systemic manifestations such as fever, weight loss and musculoskeletal pain are usually present at the onset. The patients are febrile, with leucocytosis and an increased erythrocyte sedimentation rate. They may require several weeks of hospitalization. The treatment of AF has been challenging; the response to traditional acne therapies is poor. The recommended treatment is aggressive and consists of a combination of oral steroids and isotretinoin. To avoid the relapses, duration of such treatment should not be less than 3-5 months. Although the prognosis for patients treated appropriately is good, these acute inflammatory nodules often heal with residual scarring.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2010        PMID: 21029206     DOI: 10.1111/j.1468-3083.2010.03855.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  The Immunogenetics of Acne.

Authors:  Mohamed L Elsaie; Dalia G Aly
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.

Authors:  Raed O Alhusayen; David N Juurlink; Muhammad M Mamdani; Richard L Morrow; Neil H Shear; Colin R Dormuth
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

3.  Successful Treatment of Facial Acne Fulminans: Antimicrobial Agents and Oral Prednisolone as Promising Regimes.

Authors:  Amir Hossein Siadat; Anis Bostakian; Bahareh Abtahi-Naeini; Masoom Shahbazi
Journal:  Case Rep Dermatol Med       Date:  2017-03-27

4.  Sacroiliitis during isotretinoin treatment: Causal association or coincidence?

Authors:  Ece Aydog; Gulcan Ozturk; Asuman Comert; Neslihan Tasdelen; Ozlem Akin; Duygu Geler Kulcu
Journal:  North Clin Istanb       Date:  2018-08-07

Review 5.  Truncal Acne: An Overview.

Authors:  Yu Ri Woo; Hei Sung Kim
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

6.  Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case.

Authors:  Claudio Marasca; Gabriella Fabbrocini; Luisa Abategiovanni; Elisa Camela; Mariateresa Nocerino; Adriana Di Guida; Gaia De Fata Salvatores
Journal:  Skin Appendage Disord       Date:  2021-01-21

7.  Pseudo-acne fulminans associated with oral isotretinoin.

Authors:  Luciana Rosa Grando; Oriete Gerin Leite; Tania Ferreira Cestari
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896

8.  When strength turns into disease: acne fulminans in a bodybuilder.

Authors:  Mario Perez; Lucas Navajas-Galimany; Andrea Antunez-Lay; Ariel Hasson
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.